JWH-122: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:JWH-122}} | |||
== | == Overview == | ||
JWH-122 is a | '''JWH-122''' is a synthetic cannabinoid that acts as a potent agonist of the [[cannabinoid receptor]]s. It is part of the [[naphthoylindole]] family of compounds and is used in scientific research to study the [[endocannabinoid system]]. | ||
== | == Chemical Structure == | ||
JWH-122 | [[File:JWH-122.svg|thumb|right|Chemical structure of JWH-122]] | ||
JWH-122 has a chemical structure that includes a naphthoylindole core. The full chemical name is ''1-Pentyl-3-(4-methyl-1-naphthoyl)indole''. This structure is similar to other synthetic cannabinoids, such as [[JWH-018]] and [[JWH-073]], which also belong to the naphthoylindole class. | |||
== | == Pharmacology == | ||
JWH-122 acts as a full agonist at both the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] cannabinoid receptors. It has a higher affinity for the CB1 receptor, which is primarily found in the [[central nervous system]]. This receptor interaction is responsible for the psychoactive effects associated with cannabinoids. | |||
== | == Effects == | ||
JWH-122 | The effects of JWH-122 are similar to those of [[tetrahydrocannabinol]] (THC), the primary psychoactive component of [[cannabis]]. Users may experience altered perception, mood changes, and cognitive effects. However, as a synthetic compound, JWH-122 can have unpredictable and potentially severe side effects. | ||
== | == Legal Status == | ||
Due to its potential for abuse and lack of medical use, JWH-122 is classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and "[[designer drug]]s." | |||
== Research == | |||
JWH-122 is used in research to better understand the [[endocannabinoid system]] and the effects of cannabinoid receptor activation. Studies often focus on its binding affinity, efficacy, and potential therapeutic applications. | |||
== Related pages == | |||
* [[Synthetic cannabinoids]] | |||
* [[Cannabinoid receptor]] | |||
* [[Endocannabinoid system]] | |||
* [[JWH-018]] | * [[JWH-018]] | ||
* [[JWH-073]] | * [[JWH-073]] | ||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
[[Category:Designer drugs]] | [[Category:Designer drugs]] | ||
Latest revision as of 03:57, 13 February 2025
Overview[edit]
JWH-122 is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is part of the naphthoylindole family of compounds and is used in scientific research to study the endocannabinoid system.
Chemical Structure[edit]
JWH-122 has a chemical structure that includes a naphthoylindole core. The full chemical name is 1-Pentyl-3-(4-methyl-1-naphthoyl)indole. This structure is similar to other synthetic cannabinoids, such as JWH-018 and JWH-073, which also belong to the naphthoylindole class.
Pharmacology[edit]
JWH-122 acts as a full agonist at both the CB1 and CB2 cannabinoid receptors. It has a higher affinity for the CB1 receptor, which is primarily found in the central nervous system. This receptor interaction is responsible for the psychoactive effects associated with cannabinoids.
Effects[edit]
The effects of JWH-122 are similar to those of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. Users may experience altered perception, mood changes, and cognitive effects. However, as a synthetic compound, JWH-122 can have unpredictable and potentially severe side effects.
Legal Status[edit]
Due to its potential for abuse and lack of medical use, JWH-122 is classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."
Research[edit]
JWH-122 is used in research to better understand the endocannabinoid system and the effects of cannabinoid receptor activation. Studies often focus on its binding affinity, efficacy, and potential therapeutic applications.
